Tailored exercise program for people with myeloproliferative neoplasms
Tests an individually tailored exercise program in adults with myeloproliferative neoplasms.
Plain-language title generated from the registry record
Registry title: Exercise Training in Patients With Myeloproliferative Neoplasms
Key facts
- Where
- Hanover, GermanySee the site
Where in Germany
- Hannover Medical SchoolHanover, GermanyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hannover Medical School
- Trial code
- NCT07384039
- Record updated
- 14 August 2026
- Original description
The investigators will investigate the response of an individualized exercise training program on quality of life, cardiorespiratory fitness and disease-specific markers in patients with myeloproliferative neoplasms (MPN). To this end, the investigators will randomly assign patients with MPN to a training group and a waiting control group.Read full original descriptionShow less
Effects of Individually Tailored Exercise on Quality of Life and Physical Performance in Patients With Myeloproliferative Neoplasms-a Randomized Controlled Study
The investigators will investigate the response of an individualized exercise training program on quality of life, cardiorespiratory fitness and disease-specific markers in patients with myeloproliferative neoplasms (MPN). To this end, the investigators will randomly assign patients with MPN to a training group and a waiting control group.
The training group will undergo an individually tailored exercise training program for three months, while the control group will maintain their usual lifestyle for three months and then has the opportunity to undergo the three-month intervention program. At the beginning and at the end of the three-month intervention phase, the investigators will evaluate physical performance, daily physical activity, muscular strength, and self-reported outcomes and compare them between the training and the control group, in order to assess potential benefits of the exercise training program.
Inclusion: age ≥ 18 years; diagnosis of myeloproliferative neoplasia according to WHO/ICC 2022.
Exclusion: the presence of any diseases or functional impairments that, in the opinion of the examining physician, exclude participation in a physical training intervention; current participation in another intervention study.